Neurodegenerative disorders are characterised by progressive neuron loss in specific brain
areas. The most common are Alzheimer's disease and Parkinson's disease; in both cases …

Parkinson's disease (PD) is a widespread progressive neurodegenerative disease. Clinical
diagnosis approaches are insufficient to provide an early and accurate diagnosis before a …

The pathophysiology of tremor in Parkinson's disease (PD) is evolving towards a complex
alteration to monoaminergic innervation, and increasing evidence suggests a key role of the …

Availability of PET imaging radiotracers targeting α-synuclein aggregates is important for
early diagnosis of Parkinson's disease and related α-synucleinopathies, as well as for the …

Depression is a common and devastating neuropsychiatric symptom in the elderly and in
patients with dementia. In particular, nearly 80% of patients with Alzheimer's Disease …

Assessing imaging biomarker in the prodromal and early phases of Parkinson's disease
(PD) is of great importance to ensure an early and safe diagnosis. In the last decades …

Background: The prodromal phase of Parkinson's disease (PD), much like the disease itself,
displays marked heterogeneity, with varied rates of progression and symptom severities. A …

Parkinson's disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies
(DLB) are collectively identified as synucleinopathies, a group of neurodegenerative …

A bstract Parkinson's disease (PD) is a chronic neurodegenerative disorder that is clinically
manifested by motor and non-mo tor symptoms. At the early stage of the disease, it can be …

Aim: The aim of the study was to analyze the results of semiquantitative assessment of
dopamine transporters scintigraphy n (DAT-SPECT) in patients with Parkinson's disease …